VAISHALI — Vaishali Pharma Balance Sheet
0.000.00%
- IN₹1.02bn
- IN₹862.64m
- IN₹990.26m
- 24
- 34
- 20
- 11
Annual balance sheet for Vaishali Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 121 | 130 | 124 | 135 | 300 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 667 | 585 | 536 | 501 | 477 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 813 | 764 | 727 | 745 | 1,045 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.71 | 9.04 | 18 | 14.6 | 11.6 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 861 | 816 | 789 | 800 | 1,098 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 593 | 519 | 321 | 331 | 401 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 637 | 553 | 384 | 371 | 449 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 224 | 264 | 405 | 428 | 649 |
| Total Liabilities & Shareholders' Equity | 861 | 816 | 789 | 800 | 1,098 |
| Total Common Shares Outstanding |